KIWA BIO-TECH PRODUCTS GROUP CORP Files SEC form 10-Q, Quarterly Report

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. This Quarterly Report on Form 10-Q for the three months ended September 30, 2009 contains "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates," or similar expressions. These forward-looking statements include, among others, statements concerning our expectations regarding our working capital requirements, financing requirements, business, growth prospects, competition and results of operations, and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. The forward-looking statements in this Quarterly Report on Form 10-Q for the three months ended September 30, 2009 involve known and unknown risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those expressed in or implied by the forward-looking statements contained herein. Overview The Company took its present corporate form in March 2004 when shareholders of Kiwa Bio-Tech Products Group Ltd. ("Kiwa BVI"), a company originally organized under the laws of the British Virgin Islands on June 5, 2002 and Tintic Gold Mining Company ("Tintic"), a corporation originally incorporated in the state of Utah on June 14, 1933 to perform mining operations in Utah, entered into a share exchange transaction. The share exchange transaction left the shareholders of Kiwa BVI owning a majority of Tintic and Kiwa BVI a wholly-owned subsidiary of Tintic. For accounting purposes this transaction was treated as an acquisition of Tintic by Kiwa BVI in the form of a reverse triangular merger and a recapitalization of Kiwa BVI and its wholly owned sub...
Click here to read the whole Article (external link)

Kiwa Bio-Tech Reports Third Quarter Results

BEIJING and CLAREMONT, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT - News) announced results for the third quarter and for the first nine months of 2009. Revenues for the third quarter of 2009 were $1,374,561 a decrease of 40.9% from revenues of $2,327,315 in the third quarter of 2008. This decrease was in part due to deliberate reduction in sales of low margin bio-fertilizer and bio-feed products. In addition, the Company's efforts in boosting sales revenue were partially offset by requests to customers of cash payment at the time of purchase. During the three months ended September 30, 2009, cost of sales was $1,351,838, representing a decrease of $919,934 or 40.5%, compared with $2,271,772 for the same period of 2008. The sharp decrease of cost of sales was mainly attributable to reduction of revenue. Net loss, attributable to Kiwa shareholders, for the third quarter of 2009 was $516,933 compared to a net loss, attributable to Kiwa shareholders, of $567,770 in the same period of 2008. Revenues for the first nine months of 2009 were $2,864,253 compared to $7,539,083 in the first nine months of 2008. During the nine months ended September 30, 2009, net loss attributable to Kiwa's shareholders was $1,962,356, an increase of $77,370 or 4.1%, compared with $1,884,986 for the same period of 2008. Please refer to documents filed with the Securities and Exchange Commission for additional information on the results ...
Click here to read the whole Article (external link)

KIWA BIO-TECH PRODUCTS GROUP CORP Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

Kiwa Bio-Tech 2nd Quarter Results Announced

BEIJING and CLAREMONT, Calif., Aug. 12, 2009 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT - News) announced revenues for the second quarter of 2009 ended June 30 were $831,142 compared to revenues of $3,027,497 for the second quarter of 2008. Revenues for the first six months were $1,489,751 compared to $5,211,768 the previous year. Net loss attributable to Kiwa shareholders for the three-month period ended June 30, 2009 was $623,584 (including non-cash expenses of $352,658), compared to $631,021 (including non-cash expenses of approximately $273,104) for the three months ended June 30, 2008. Please refer to documents filed today with the Securities and Exchange Commission for additional information on the results for the second quarter of 2009. The Company is actively adjusting the mix of bio-fertilizer and animal feed products with a goal of improving gross margins. This has led to a decrease in revenues of low-profit-margin products. In addition, the Company's efforts to boost sales revenue were partially offset by request to customers of cash payment at the time of purchasing. ABOUT KIWA BIO-TECH PRODUCTS GROUP CORPORATION The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decrea...
Click here to read the whole Article (external link)

KIWA BIO-TECH PRODUCTS GROUP CORP Files SEC form 10-Q, Quarterly Report

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. This Quarterly Report on Form 10-Q for the three months ended June 30, 2009 contains "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates," or similar expressions. These forward-looking statements include, among others, statements concerning our expectations regarding our working capital requirements, financing requirements, business, growth prospects, competition and results of operations, and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. The forward-looking statements in this Quarterly Report on Form 10-Q for the three months ended June 30, 2009 involve known and unknown risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those expressed in or implied by the forward-looking statements contained herein. Overview The Company took its present corporate form in March 2004 when shareholders of Kiwa Bio-Tech Products Group Ltd. ("Kiwa BVI"), a company originally organized under the laws of the British Virgin Islands on June 5, 2002 and Tintic Gold Mining Company ("Tintic"), a corporation originally incorporated in the state of Utah on June 14, 1933 to perform mining operations in Utah, entered into a share exchange transaction. The share exchange transaction left the shareholders of Kiwa BVI owning a majority of Tintic and Kiwa BVI a wholly-owned subsidiary of Tintic. For accounting purposes this transaction was treated as an acquisition of Tintic by Kiwa BVI in the form of a reverse triangular merger and a recapitalization of Kiwa BVI and its wholly owned subsidiary, Ki...
Click here to read the whole Article (external link)

Kiwa Bio-Tech First Quarter 2009 Results Announced

BEIJING and CLAREMONT, Calif., June 15, 2009 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBTE - News) announced results for the first quarter ended March 31, 2009. Net sales were $658,524 and $2,184,271 for the three months ended March 31, 2009 and 2008, respectively. The net loss attributable to Kiwa shareholders for the first quarter was $818,125 in 2009 and $686,195 in 2008. During three months ended March 31, 2009, limited capital resources has lowered the capability of purchasing raw materials for the bio-fertilizer operations. The Company's efforts in boosting fertilizer sales revenues were partially offset by requiring customers to pay cash at the time of purchase rather than extending credit. The decrease in revenue in the bio-feed operations was due to adjustments in product mix by dropping low-profit-margin fowl feeds. Please refer to our 10Q report filed today with the Securities and Exchange Commission for additional information on the results and operations. Kiwa recently received a Notice of Default from 6% Notes and 2% Notes Purchasers. The Notice of Default stated that the Company is in default of Section 3.3 under the 6% Notes and 2% Notes and declared an event of default under the 6% Notes and 2% Notes. The Company has engaged in discussion with the Investors to resolve the matter. Kiwa continues to seek capital to strengthen its balance sheet and enable it to take advantage of opportunities supplying the Chinese agricultural industries with animal ...
Click here to read the whole Article (external link)

KIWA BIO-TECH PRODUCTS GROUP CORP Files SEC form 10-Q, Quarterly Report

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. This Quarterly Report on Form 10-Q for the three months ended March 31, 2009 contains "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates," or similar expressions. These forward-looking statements include, among others, statements concerning our expectations regarding our working capital requirements, financing requirements, business, growth prospects, competition and results of operations, and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. The forward-looking statements in this Quarterly Report on Form 10-Q for the three months ended March 31, 2009 involve known and unknown risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those expressed in or implied by the forward-looking statements contained herein. Overview The Company took its present corporate form in March 2004 when shareholders of Kiwa Bio-Tech Products Group Ltd. ("Kiwa BVI"), a company originally organized under the laws of the British Virgin Islands on June 5, 2002 and Tintic Gold Mining Company ("Tintic"), a corporation originally incorporated in the state of Utah on June 14, 1933 to perform mining operations in Utah, entered into a share exchange transaction. The share exchange transaction left the shareholders of Kiwa BVI owning a majority of Tintic and Kiwa BVI a wholly-owned subsidiary of Tintic. For accounting purposes this transaction was treated as an acquisition of Tintic by Kiwa BVI in the form of a reverse triangular merger and a recapitalization of Kiwa BVI and its wholly owned subsidia...
Click here to read the whole Article (external link)

KIWA BIO-TECH PRODUCTS GROUP CORP Files SEC form 10-Q, Quarterly Report

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. This Quarterly Report on Form 10-Q for the three months ended March 31, 2009 contains "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates," or similar expressions. These forward-looking statements include, among others, statements concerning our expectations regarding our working capital requirements, financing requirements, business, growth prospects, competition and results of operations, and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. The forward-looking statements in this Quarterly Report on Form 10-Q for the three months ended March 31, 2009 involve known and unknown risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those expressed in or implied by the forward-looking statements contained herein. Overview The Company took its present corporate form in March 2004 when shareholders of Kiwa Bio-Tech Products Group Ltd. ("Kiwa BVI"), a company originally organized under the laws of the British Virgin Islands on June 5, 2002 and Tintic Gold Mining Company ("Tintic"), a corporation originally incorporated in the state of Utah on June 14, 1933 to perform mining operations in Utah, entered into a share exchange transaction. The share exchange transaction left the shareholders of Kiwa BVI owning a majority of Tintic and Kiwa BVI a wholly-owned subsidiary of Tintic. For accounting purposes this transaction was treated as an acquisition of Tintic by Kiwa BVI in the form of a reverse triangular merger and a recapitalization of Kiwa BVI and its wholly owned subsidia...
Click here to read the whole Article (external link)

KIWA BIO-TECH PRODUCTS GROUP CORP Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

KIWA BIO-TECH PRODUCTS GROUP CORP Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financia

Show all filings for KIWA BIO-TECH PRODUCTS GROUP CORP | Request a Trial to NEW EDGAR Online Pro Form 8-K for KIWA BIO-TECH PRODUCTS GROUP CORP 9-Jun-2009Triggering Events That Accelerate or Increase a Direct Financia Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All informati...
Click here to read the whole Article (external link)